Enanta Pharmaceuticals Inc
ENTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001177648
No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Enanta Pharmaceuticals Inc changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 122 | 2 | 132 | +12 |
| Shares | 19.0M | 50.7K | 26.4M | +7.45M (+39.3%) |
| Value | $227.1M | $607.1K | $416.1M | +$189.6M (+83.7%) |
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (36)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (24)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Commodore Capital LP | 800,000 | $9.58M |
| Jacobs Levy Equity Management, Inc | 169,048 | $2.02M |
| Trexquant Investment LP | 127,363 | $1.52M |
| Tang Capital Management LLC | 126,655 | $1.52M |
| StemPoint Capital LP | 75,194 | $900.1K |
| Graham Capital Management, L.P. | 37,323 | $446.8K |
| PharVision Advisers, LLC | 35,846 | $429.1K |
| HRT Financial LP | 33,188 | $397.0K |
| Skopos Labs, Inc. | 43,153 | $323.6K |
| Jane Street Group, LLC | 19,165 | $229.4K |
| Ameriprise Financial Inc | 18,007 | $215.5K |
| Gsa Capital Partners LLP | 17,856 | $214.0K |
| Occudo Quantitative Strategies LP | 15,549 | $186.1K |
| Public Employees Retirement System of Ohio | 14,412 | $172.5K |
| Harvest Investment Services, LLC | 12,193 | $145.9K |
| Algert Global LLC | 11,106 | $132.9K |
| Tudor Investment Corp Et Al | 10,443 | $125.0K |
| HSBC Holdings PLC | 10,415 | $124.5K |
| Quarry LP | 6,752 | $80.8K |
| Group One Trading, L.P. | 800 | $9.58K |
| Sachetta, LLC | 100 | $1.20K |
| Clearstead Advisors, LLC | 56 | $671 |
| Jones Financial Companies LLLP | 60 | $474 |
| Advisory Services Network, LLC | 4 | $48 |
Not filed for Q4 2025 yet (2)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 49,983 | $598.3K |
| Point72 (DIFC) Ltd | 739 | $8.85K |